Literature DB >> 11853541

13C-NMR study of the inhibition of delta-chymotrypsin by a tripeptide-glyoxal inhibitor.

Aleksandra Djurdjevic-Pahl1, Chandralal Hewage, J Paul G Malthouse.   

Abstract

A new inhibitor, Z-Ala-Pro-Phe-glyoxal (where Z is benzyloxycarbonyl),has been synthesized and shown to be a competitive inhibitor of delta-chymotrypsin, with a K(i) of 25+/-8 nM at pH 7.0 and 25 degrees C. Z-Ala-Pro-[1-(13)C]Phe-glyoxal and Z-Ala-Pro-[2-(13)C]Phe-glyoxal have been synthesized, and (13)C-NMR has been used to determine how they interact with delta-chymotrypsin. Using Z-Ala-Pro-[2-(13)C]Phe-glyoxal we have detected a signal at 100.7 p.p.m. which we assign to the tetrahedral adduct formed between the hydroxy group of Ser-195 and the (13)C-enriched keto-carbon of the inhibitor. This signal is in a pH-dependent slow exchange with a signal at 107.6 p.p.m. which depends on a pK(a) of approximately 4.5, which we assign to oxyanion formation. Thus we are the first to detect an oxyanion pK(a) in a reversible chymotrypsin-inhibitor complex. A smaller titration shift of 100.7 p.p.m. to 103.9 p.p.m. with a pK(a) of approximately 5.3 is also detected due to a rapid exchange process. This pK(a) is also detected with the Z-Ala-Pro-[1-(13)C]Phe-glyoxal inhibitor and gives a larger titration shift of 91.4 p.p.m. to 97.3 p.p.m., which we assign to the ionization of the hydrated aldehyde hydroxy groups of the enzyme-bound inhibitor. Protonation of the oxyanion in the oxyanion hole decreases the binding efficiency of the inhibitor. From this decrease in binding efficiency we estimate that oxyanion binding in the oxyanion hole reduces the oxyanion pK(a) by 1.3 pK(a) units. We calculate that the pK(a)s of the oxyanions of the hemiketal and hydrated aldehyde moieties of the glyoxal inhibitor are both lowered by 6.4-6.9 pK(a) units on binding to chymotrypsin. Therefore we conclude that oxyanion binding in the oxyanion hole has only a minor role in decreasing the oxyanion pK(a). We also investigate how the inhibitor breaks down at alkaline pH, and how it breaks down at neutral pH in the presence of chymotrypsin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853541      PMCID: PMC1222393          DOI: 10.1042/0264-6021:3620339

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Correlation of low-barrier hydrogen bonding and oxyanion binding in transition state analogue complexes of chymotrypsin.

Authors:  D Neidhart; Y Wei; C Cassidy; J Lin; W W Cleland; P A Frey
Journal:  Biochemistry       Date:  2001-02-27       Impact factor: 3.162

2.  13C nuclear magnetic resonance study of the cis-trans isomerism in X-Pro-Pro tripeptides.

Authors:  R E London; N A Matwiyoff; J M Stewart; J R Cann
Journal:  Biochemistry       Date:  1978-06-13       Impact factor: 3.162

3.  A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors.

Authors:  P J Henderson
Journal:  Biochem J       Date:  1972-04       Impact factor: 3.857

4.  Radiosensitization of bacterial and mammalian cells by substituted glyoxals.

Authors:  M J Ashwood-Smith; D M Robinson; J H Barnes; B A Bridges
Journal:  Nature       Date:  1967-10-14       Impact factor: 49.962

5.  Total synthesis of a monocyclic peptide lactone antibiotic, etamycin.

Authors:  J C Sheehan; S L Ledis
Journal:  J Am Chem Soc       Date:  1973-02-07       Impact factor: 15.419

6.  Subtilisin; a stereochemical mechanism involving transition-state stabilization.

Authors:  J D Robertus; J Kraut; R A Alden; J J Birktoft
Journal:  Biochemistry       Date:  1972-11-07       Impact factor: 3.162

7.  Proton magnetic resonance studies of alpha-keto acids.

Authors:  A J Copper; A G Redfield
Journal:  J Biol Chem       Date:  1975-01-25       Impact factor: 5.157

8.  13C NMR study of the ionizations within a trypsin-chloromethyl ketone inhibitor complex.

Authors:  J P Malthouse; W U Primrose; N E Mackenzie; A I Scott
Journal:  Biochemistry       Date:  1985-07-02       Impact factor: 3.162

9.  Affinity labelling of proteinases with tryptic specificity by peptides with C-terminal lysine chloromethyl ketone.

Authors:  J R Coggins; W Kray; E Shaw
Journal:  Biochem J       Date:  1974-03       Impact factor: 3.857

10.  A 13C-n.m.r. investigation of ionizations within a trypsin-inhibitor complex. Evidence that the pKa of histidine-57 is raised by interaction with the hemiketal oxyanion.

Authors:  W U Primrose; A I Scott; N E Mackenzie; J P Malthouse
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

View more
  5 in total

1.  A 13C-NMR study of the inhibition of papain by a dipeptide-glyoxal inhibitor.

Authors:  Jonathan Lowther; Aleksandra Djurdjevic-Pahl; Chandralal Hewage; J Paul G Malthouse
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

2.  A new lysine derived glyoxal inhibitor of trypsin, its properties and utilization for studying the stabilization of tetrahedral adducts by trypsin.

Authors:  Jennifer A Cleary; J Paul G Malthouse
Journal:  Biochem Biophys Rep       Date:  2016-01-04

3.  Quantifying tetrahedral adduct formation and stabilization in the cysteine and the serine proteases.

Authors:  Jennifer A Cleary; William Doherty; Paul Evans; J Paul G Malthouse
Journal:  Biochim Biophys Acta       Date:  2015-07-11

4.  Kinetic Studies of the Effect of pH on the Trypsin-Catalyzed Hydrolysis of N-α-benzyloxycarbonyl-l-lysine-p-nitroanilide: Mechanism of Trypsin Catalysis.

Authors:  J Paul G Malthouse
Journal:  ACS Omega       Date:  2020-03-03

5.  Hemiacetal stabilization in a chymotrypsin inhibitor complex and the reactivity of the hydroxyl group of the catalytic serine residue of chymotrypsin.

Authors:  Jennifer A Cleary; William Doherty; Paul Evans; J Paul G Malthouse
Journal:  Biochim Biophys Acta       Date:  2014-03-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.